戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 and subcutaneous fat deposition and markedly abnormal glucose tolerance.
2 Nine of 23 subjects with cystic fibrosis had abnormal glucose tolerance (39%; P = 0.03).
3 for both type 2 diabetes (9.7, 4.3-22.0) and abnormal glucose tolerance (9.0, 4.2-19.7).
4                                              Abnormal glucose tolerance (AGT; diabetes or impaired gl
5                         The CF subjects with abnormal glucose tolerance also had de novo lipogenesis.
6  12 clinically stable adult CF patients with abnormal glucose tolerance and 12 age-, sex-, and lean b
7 y was designed to quantify the prevalence of abnormal glucose tolerance and insulin resistance in pat
8       We show that the Fem1b-KO mice display abnormal glucose tolerance and that this is due predomin
9                       Insulin resistance and abnormal glucose tolerance are more prevalent in patient
10             All differences in prevalence of abnormal glucose tolerance between ADA and WHO classific
11 t atrial (LA) measures within the normal and abnormal glucose tolerance categories (the latter includ
12 l diabetes were slightly more likely to have abnormal glucose tolerance compared with those with pate
13 Rs (95% CI) for offspring type 2 diabetes or abnormal glucose tolerance (fasting plasma glucose > or
14 d across HOMA-IR quartiles in the normal and abnormal glucose tolerance groups in both sexes.
15 s disease (PD) and Type 2 Diabetes (T2D), as abnormal glucose tolerance has been reported in >50% of
16        We aimed to compare the prevalence of abnormal glucose tolerance identified by the 1985 WHO an
17 a cell-specific ARNT knockout mice exhibited abnormal glucose tolerance, impaired insulin secretion,
18 t risk for a mild slowly progressive form of abnormal glucose tolerance in addition to overt diabetes
19 sistance contribute to the high incidence of abnormal glucose tolerance in CF.
20 n men and may contribute to the high risk of abnormal glucose tolerance in this population.
21                                     Although abnormal glucose tolerance is a well-established risk fa
22                          In cystic fibrosis, abnormal glucose tolerance is associated with decreased
23                                              Abnormal glucose tolerance is notably prevalent among yo
24        Translational evidence indicates that abnormal glucose tolerance may begin in early life.
25         In subjects with normal (n=2022) and abnormal glucose tolerance (n=327), covariate-adjusted L
26 insulin secretion is impaired in people with abnormal glucose tolerance, nonglucose nutrient-induced
27 tures (RP with blindness by age 13, BMI >45, abnormal glucose tolerance test and IQ=64, vaginal atres
28             Metabolism investigations showed abnormal glucose tolerance tests and low HDL values in s
29 actors and, among at-risk women, testing for abnormal glucose tolerance that is usually, but not inva

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。